We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-14.64%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$683B
AUM Growth
-$118B
Cap. Flow
+$16.8B
Cap. Flow %
2.46%
Top 10 Hldgs %
22.55%
Holding
5,106
New
131
Increased
2,878
Reduced
1,465
Closed
89

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$956M
2
AAPL icon
Apple
AAPL
+$935M
3
WBD icon
Warner Bros
WBD
+$783M
4
HD icon
Home Depot
HD
+$626M
5
AMZN icon
Amazon
AMZN
+$476M

Sector Composition

Rank Sector Weight
1 Technology 23.95%
2 Healthcare 14.76%
3 Financials 13.17%
4 Consumer Discretionary 10.3%
5 Industrials 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QNGY
4676
DELISTED
Quanergy Systems, Inc.
QNGY
$77K ﹤0.01%
9,416
+5,596
+146% +$126K
TSRI
4677
DELISTED
TSR Inc. New
TSRI
$77K ﹤0.01%
10,404
+167
+2% +$1.39K
INBS icon
4678
Intelligent Bio Solutions
INBS
$4.9M
$76K ﹤0.01%
48
+1
+2% +$1.69K
TMBR
4679
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$75K ﹤0.01%
4,787
+673
+16% +$9.81K
NAVB
4680
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$75K ﹤0.01%
104,619
+7,413
+8% +$6.3K
PTIX
4681
DELISTED
Performance Technologies
PTIX
$74K ﹤0.01%
1,855
SOPH icon
4682
SOPHiA GENETICS
SOPH
$638M
$74K ﹤0.01%
20,681
XBIO icon
4683
Xenetic Biosciences
XBIO
$7.38M
$74K ﹤0.01%
9,260
+165
+2% +$1.33K
PETV
4684
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
$74K ﹤0.01%
47,163
+6,043
+15% +$11.4K
LIQT icon
4685
LiqTech
LIQT
$23.1M
$73K ﹤0.01%
20,509
WPRT
4686
Westport Fuel Systems
WPRT
$36.7M
$73K ﹤0.01%
7,240
ALNA
4687
DELISTED
Allena Pharmaceuticals
ALNA
$73K ﹤0.01%
386,352
+50,779
+15% +$7.87K
CALC icon
4688
CalciMedica
CALC
$10.4M
$72K ﹤0.01%
4,742
+624
+15% +$8.52K
ELUT icon
4689
Elutia
ELUT
$35.4M
$72K ﹤0.01%
+10,275
New +$66.3K
UXIN
4690
Uxin Ltd
UXIN
$257M
$72K ﹤0.01%
1,722
KXIN icon
4691
Kaixin Holdings
KXIN
$8.43M
0
CALA
4692
DELISTED
Calithera Biosciences, Inc
CALA
$71K ﹤0.01%
29,245
-225
-0.8% -$1.04K
CHGA
4693
Change Agents Corporation Common Stock
CHGA
$2.83M
$70K ﹤0.01%
984
+17
+2% +$1.42K
BNTC icon
4694
Benitec Biopharma
BNTC
$463M
$70K ﹤0.01%
3,558
+54
+2% +$1.26K
MYSE
4695
Myseum.AI Inc
MYSE
$12.8M
$70K ﹤0.01%
6,555
+247
+4% +$3.68K
ICMB icon
4696
Investcorp Credit Management BDC
ICMB
$12.5M
$70K ﹤0.01%
16,938
CRDL
4697
Cardiol Therapeutics
CRDL
$173M
$69K ﹤0.01%
52,435
SINT icon
4698
SiNtx Technologies
SINT
$11.3M
$69K ﹤0.01%
8
LFLY
4699
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$69K ﹤0.01%
776
-7,007
-90% -$1.21M
ELVN icon
4700
Enliven Therapeutics
ELVN
$4.31B
$68K ﹤0.01%
13,935
+319
+2% +$1.56K

Similar funds

Geode Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Geode Capital Management held 5,106 positions worth $683B, down 15% from $801B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 4.3%. Geode Capital Management opened 131 new positions and exited 89, leaving the 5,106-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2022 buy was Aspen Technology Inc: 402,046 shares worth $74M.
  • Geode Capital Management added most to Microsoft in Q2 2022, an estimated $956M increase.
  • Geode Capital Management's biggest Q2 2022 reduction was AT&T, cutting an estimated $734M.
  • Geode Capital Management fully exited Cerner Corp in Q2 2022, selling an estimated $600M.
  • Geode Capital Management's ten largest holdings make up 23% of its $683B portfolio in Q2 2022.
  • Geode Capital Management opened 131 new positions and closed 89 in Q2 2022.
  • Geode Capital Management's portfolio value fell 15% quarter-over-quarter to $683B.

Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.